The PCC had recently published an issues paper and a policy note identifying the key challenges and potential competition issues in the Philippine pharmaceutical industry.
To aid and assist you in navigating through these new developments, we have summarized the PCC’s policy note and issues paper, and have likewise included other resources which you may use as reference to ensure your company’s continued compliance with the Philippine Competition Act (“PCA“) and its implementing rules and regulations (“PCA-IRR“).
We hope you find this useful and we welcome any feedback. Moreover, if you would like to discuss relevant or similar issues with us, please let me know and we can arrange a more bespoke discussion at your convenience.
Maria Christina Macasaet-Acaban
Partner and Head
Competition Focus Group
Healthcare & Life Sciences Industry Group
Read full alert here
*Authored by Quisumbing Torres, a member firm of Baker & McKenzie International, a Swiss Verein. Please contact QTInfoDesk@quisumbingtorres.com for inquiries.